Post-coupling strategy enables true receptor-targeted nanoparticles

Journal of RNAi and Gene Silencing

Volumn 7, Issue 1, 2011, Pages 449-455

  Chen, Jianmeizi ^a   Jorgensen, Michael R ^a   Thanou, Maya ^b   Miller, Andrew D ^a,b  

^a Flowers Building ^*  (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cellular uptake; Delivery; Integrin ligand; Integrin receptor; Nanoparticles; RNAi; siRNA

Indexed keywords

EID: 80053538507     PISSN: 17470854     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Andreu A, Fairweather N and Miller AD. 2008. Clostridium neurotoxin fragments as potential targeting moieties for liposomal gene delivery to the CNS. ChemBioChem, 9, 219-231.
2. Carmona S, Jorgensen MR, Kolli S et al. 2009. Controlling HBV replication in vivo by intravenous administration of triggered PEGylated siRNA-nanoparticles. Mol Pharmaceutics, 6, 706-717.
3. Castro E. 1990. Kinetics and mechanism of the reactions of 2,4-dinitrophenyl acetate with secondary alicyclic amines. Different nucleofugalities of alicyclic amines and pyridines from a tetrahedral intermediate. J Org Chem, 55, 1676-1679.
4. Chen XY, Park R, Shahinian AH, Bading JR and Conti PS. 2004. Pharmacokinetics and tumor retention of I-125-labeled RGD peptide are improved by PEGylation. Nuclear Med Biol, 31, 11-19.
5. Cooper RG, Harbottle RP, Schneider H, Coutelle C and Miller AD. 1999. Peptide mini-vectors for gene delivery. Angew Chem Int Ed, 38, 1949-1952.
6. DiCara D, Burman A, Clark S et al. 2008. Foot-and-mouth disease virus forms a highly stable, EDTA-resistant complex with its principal receptor, integrin αvβ6: implications for infectiousness. J Virol, 82, 1537-1546.
7. 6 ligands. J Biol Chem, 282, 9657-9665.
8. Harbottle RP, Cooper, RG, Hart SL et al. 1998. An RGDoligolysine peptide: a prototype construct for integrin-mediated gene delivery. Human Gene Ther, 9, 1037-1047.
9. 6 with an improved radiotracer and its relevance in a pancreatic tumor model. Cancer Res, 69, 5843-5850.
10. Hausner SH, DiCara D, Marik J, Marshall JF and Sutcliffe JL. 2007. Use of a peptide derived from foot-and-mouth disease virus for the noninvasive imaging of human cancer: generation and evaluation of 4-[18F]fluorobenzoyl A20FMDV2 for in vivo imaging of integrin αvβ6 expression with positron emission tomography. Cancer Res, 67, 7833-7840.
11. Kamaly N, Kalber T, Kenny G, Bell J, Jorgensen M and Miller AD. 2010. A novel bimodal lipidic contrast agent for cellular labelling and tumour MRI. Org Biomol Chem, 8, 201-211.
12. Kamaly N, Kalber T, Thanou M, Bell JD and Miller AD. 2009. Folate receptor targeted bimodal liposomes for tumor magnetic resonance imaging. Bioconjug Chem, 20, 648-655.
13. Keller M, Jorgensen MR, Perouzel E and Miller AD. 2003. Thermodynamic aspects and biological profile of CDAN/DOPE and DC-Chol/DOPE lipoplexes. Biochemistry, 42, 6067-6077.
14. Kenny GD, Kamaly N, Kalber TL et al. 2011. Novel Multifunctional Nanoparticle Mediates siRNA Tumour Delivery, Visualisation and Therapeutic Tumour Reduction In vivo. J Control Rel, 149, 111-116.
15. Kostarelos K and Miller AD. 2005. Synthetic, self-assembly ABCD nanoparticles; a structural paradigm for viable synthetic non-viral vectors. Chem Soc Rev, 34, 970-994.
16. Mével M, Kamaly N, Carmona S et al. 2010. DODAG; a versatile new cationic lipid that mediates efficient delivery of pDNA and siRNA. J Control Rel, 143, 222-232.
17. Miller AD. 2008a. Synthetic nucleic acid delivery systems in gene therapy. In: Encyclopedia of Life Sciences. J Wiley & Sons, Chichester, UK.
18. Miller AD. 2008b. Towards safe nanoparticle technologies for nucleic acid therapeutics. Tumori, 94, 234-245.
19. Oliver M, Jorgensen MR and Miller AD. 2004. The facile solidphase synthesis of cholesterol-based polyamine lipids. Tetrahedron Lett, 45, 3105-3108.
20. Thanou M, Waddington S and Miller AD. 2007. Gene Therapy. In: Taylor JB and Triggle DJ (Eds) Comprehensive Medicinal Chemistry II. Elsevier, Oxford, 297-320.
21. Wang M, Löwik DW, Miller AD and Thanou M. 2009. Targeting the urokinase plasminogen activator receptor with synthetic self-assembly nanoparticles. Bioconjug Chem, 20, 32-40.
22. Waterhouse JE, Harbottle RP, Keller M et al. 2005. Synthesis and Application of Integrin Targeting Lipopeptides in Targeted Gene Delivery. ChemBioChem, 6, 1212-1223.